ArticleBlood advances2022
Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation.
Siok-Keen Tey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it